Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
87.60%
Operating Margin
3.77%
Net Margin
2.34%
Efficiency Metrics
Revenue per Expense Ratio
1.04
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
4.63%
Income Tax Rate
24.71%
EPS
20.0900000000
Balance Sheet Analysis
Current Ratio
0.25
Cash Ratio
0.25
Working Capital
$-14.18B
Debt to Equity
0.75
Debt to Assets
26.07%
Equity Ratio
34.55%
Cash Flow Analysis
Operating Cash Flow Ratio
3.74%
Free Cash Flow Ratio
2.80%
CapEx to Revenue
0.94%
Dividends Paid
$431.00M
Stock Buybacks
$1.57B
Total Shareholder Returns
$2.00B
Cash Position Change
-7.25%
Key Takeaways (2023 FY)
Increased dividend payments by 12.22%
Detailed Growth Metrics
Core Performance
Revenue
14.54%
Net Income
-11.30%
EPS
-9.50%
Operating Income
5.61%
Operational Efficiency
R&D Expenses
0.00%
SG&A Expenses
-100.00%
Operating Cash Flow
-13.21%
Free Cash Flow
-14.13%
Balance Sheet Health
Assets
9.31%
Debt
2.03%
Book Value per Share
-51.05%
Inventory
100.00%
Shareholder Returns
Dividends per Share
12.22%
Shares Outstanding
-2.02%
Long Term Trends
3Y Revenue/Share
47.15%
5Y Revenue/Share
107.46%
3Y Dividend/Share
42.41%
5Y Dividend/Share
80.53%